OZEM vs. IBRN ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to iShares Neuroscience and Healthcare ETF (IBRN)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.29
Average Daily Volume
36,922
14
IBRN
iShares Neuroscience and Healthcare ETF
IBRN Description
iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$25.89
Average Daily Volume
316
45
Performance
| Period | OZEM | IBRN |
|---|---|---|
| 30 Days | -11.57% | -5.38% |
| 60 Days | -11.91% | 5.36% |
| 90 Days | -9.84% | 2.59% |
| 12 Months | 26.71% |
1 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in IBRN | Overlap | |
|---|---|---|---|---|---|
| SRRK | C | 2.78% | 3.17% | 2.78% |
OZEM Underweight 44 Positions Relative to IBRN
| Symbol | Grade | Weight | |
|---|---|---|---|
| BHVN | C | -4.9% | |
| PTCT | B | -4.75% | |
| ITCI | B | -4.2% | |
| CPRX | C | -4.08% | |
| XENE | D | -3.95% | |
| ACAD | C | -3.72% | |
| ALKS | B | -3.63% | |
| NBIX | D | -3.54% | |
| EWTX | C | -3.53% | |
| AXNX | A | -3.46% | |
| LBPH | A | -3.33% | |
| SUPN | B | -3.22% | |
| SRPT | F | -3.19% | |
| BIIB | F | -2.91% | |
| DYN | F | -2.91% | |
| IART | C | -2.69% | |
| AVDL | F | -2.4% | |
| PRAX | C | -2.12% | |
| SAVA | C | -1.9% | |
| PRTA | F | -1.37% | |
| AVXL | C | -1.26% | |
| NGNE | D | -1.17% | |
| ANNX | D | -1.01% | |
| DNTH | D | -0.97% | |
| CAPR | B | -0.97% | |
| SGMO | C | -0.95% | |
| AXGN | D | -0.87% | |
| RAPP | C | -0.8% | |
| ZVRA | B | -0.78% | |
| ALEC | F | -0.73% | |
| TRDA | B | -0.71% | |
| LRMR | D | -0.55% | |
| VYGR | F | -0.54% | |
| VNDA | C | -0.48% | |
| AMLX | C | -0.46% | |
| CLPT | D | -0.46% | |
| CTNM | C | -0.43% | |
| ABEO | C | -0.42% | |
| TSHA | D | -0.39% | |
| SLDB | F | -0.32% | |
| NVRO | F | -0.29% | |
| ABOS | D | -0.25% | |
| PEPG | F | -0.21% | |
| ANRO | F | -0.16% |
OZEM: Top Represented Industries & Keywords
IBRN: Top Represented Industries & Keywords
Compare ETFs
